Discoidin domain receptor 2 (DDR2) promotes breast cancer cell metastasis and the mechanism implicates epithelial–mesenchymal transition programme under hypoxia

A wide range of genes involved in breast cancer metastasis have been reported to be related to the microenvironment. We studied the role of discoidin domain receptor 2 (DDR2), a collagen‐binding receptor, in breast cancer progression under hypoxic conditions. We showed that DDR2 protein expression closely correlated with the expression of hypoxic marker HIF‐1α in clinical breast cancer specimens. The in vitro data demonstrated that hypoxia treatment increased the levels of both expression and phosphorylation of DDR2 in human breast cancer cell lines. In vivo, orthotopic breast tumour xenografts with DDR2 knockdown displayed reduced dissemination and significant prevention in pulmonary and lymphatic metastasis; conversely, these processes were significantly facilitated by the enforced expression of the activated form of DDR2. Further mechanism studies indicated that DDR2 plays an indispensable role in a series of hypoxia‐induced behaviours of breast cancer cells, including migration, invasion, and epithelial–mesenchymal transition (EMT). The transcription factor Snail was found to mediate DDR2‐induced down‐regulation of the cell–cell adhesion molecule E‐cadherin. It was also documented that there is a correlation between DDR2 and E‐cadherin expression with the presence of lymph node metastases in 160 cases of invasive human breast carcinoma. In addition, we provided evidence that DDR2 silencing in breast cancer cells prevents the hypoxia‐induced activation of ERK MAPK, suggesting its potential involvement in mediating the effect of DDR2 on hypoxia‐induced signalling. Based on the results of this study, we conclude that DDR2 participates in hypoxia‐induced breast cancer metastasis through the regulation of cell migration, invasion, and EMT, and thus may serve as an accessible therapeutic target for the treatment of breast cancer.Copyright © 2014 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

[1]  M. Meyerson,et al.  Mutations in the DDR2 kinase gene identify a novel therapeutic target in squamous cell lung cancer. , 2011, Cancer discovery.

[2]  V. McCormack,et al.  Breast Density and Parenchymal Patterns as Markers of Breast Cancer Risk: A Meta-analysis , 2006, Cancer Epidemiology Biomarkers & Prevention.

[3]  C. Rueden,et al.  Bmc Medicine Collagen Density Promotes Mammary Tumor Initiation and Progression , 2022 .

[4]  S. Friedman,et al.  Discoidin Domain Receptor 2 Regulates Fibroblast Proliferation and Migration through the Extracellular Matrix in Association with Transcriptional Activation of Matrix Metalloproteinase-2* , 2002, The Journal of Biological Chemistry.

[5]  Paolo P. Provenzano,et al.  Collagen reorganization at the tumor-stromal interface facilitates local invasion , 2006, BMC medicine.

[6]  A. Kwan,et al.  The discoidin domain receptor DDR2 is a receptor for type X collagen. , 2006, Matrix biology : journal of the International Society for Matrix Biology.

[7]  L. Murphy,et al.  Activated mitogen-activated protein kinase expression during human breast tumorigenesis and breast cancer progression. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[8]  K. Shyu,et al.  Regulation of Discoidin Domain Receptor 2 by Cyclic Mechanical Stretch in Cultured Rat Vascular Smooth Muscle Cells , 2005, Hypertension.

[9]  C. Ford,et al.  Sensing extracellular matrix: an update on discoidin domain receptor function. , 2006, Cellular signalling.

[10]  E. Goldsmith,et al.  The Collagen Receptor DDR2 Is Expressed During Early Cardiac Development , 2010, Anatomical record.

[11]  Kevin W. Eliceiri,et al.  The collagen receptor discoidin domain receptor 2 stabilizes SNAIL1 to facilitate breast cancer metastasis , 2013, Nature Cell Biology.

[12]  N. Oku,et al.  Proteomic characterization of angiogenic endothelial cells stimulated with cancer cell-conditioned medium. , 2007, Biological & pharmaceutical bulletin.

[13]  A. Józkowicz,et al.  HIF-1 and HIF-2 transcription factors — Similar but not identical , 2010, Molecules and cells.

[14]  K. Reddy,et al.  Role of MAP kinase in tumor progression and invasion , 2003, Cancer and Metastasis Reviews.

[15]  Alex McFadden,et al.  Organization of fibroblasts in the heart , 2004, Developmental dynamics : an official publication of the American Association of Anatomists.

[16]  前山 倫子.  Switching in discoid domain receptor expressions in SLUG-induced epithelial-mesenchymal transition , 2009 .

[17]  G. Berx,et al.  DeltaEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells , 2005, Oncogene.

[18]  H. Beug,et al.  Diverse cellular and molecular mechanisms contribute to epithelial plasticity and metastasis , 2003, Nature Reviews Molecular Cell Biology.

[19]  Joong-Won Park,et al.  Dual action of a selective cyclooxygenase-2 inhibitor on vascular endothelial growth factor expression in human hepatocellular carcinoma cells: novel involvement of discoidin domain receptor 2 , 2011, Journal of Cancer Research and Clinical Oncology.

[20]  Patricia Renard,et al.  Role of ERK and calcium in the hypoxia‐induced activation of HIF‐1 , 2003, Journal of cellular physiology.

[21]  J. Thiery.  Epithelial–mesenchymal transitions in tumour progression , 2002, Nature Reviews Cancer.

[22]  M J Bissell,et al.  Involvement of extracellular matrix constituents in breast cancer. , 1995, Seminars in cancer biology.

[23]  G. Berx,et al.  Regulatory networks defining EMT during cancer initiation and progression , 2013, Nature Reviews Cancer.

[24]  L. Yao,et al.  Increased expression of discoidin domain receptor 2 (DDR2): a novel independent prognostic marker of worse outcome in breast cancer patients , 2013, Medical Oncology.

[25]  Kou-Juey Wu,et al.  TWIST activation by hypoxia inducible factor-1 (HIF-1): Implications in metastasis and development , 2008, Cell cycle.

[26]  L. Walsh,et al.  Discoidin domain receptor 2 is a critical regulator of epithelial-mesenchymal transition. , 2011, Matrix biology : journal of the International Society for Matrix Biology.

[27]  Norman Boyd,et al.  The Association of Measured Breast Tissue Characteristics with Mammographic Density and Other Risk Factors for Breast Cancer , 2005, Cancer Epidemiology Biomarkers & Prevention.

[28]  T. Pawson,et al.  The discoidin domain receptor tyrosine kinases are activated by collagen. , 1997, Molecular cell.

[29]  J. Goergen,et al.  The collagen receptor DDR2 regulates proliferation and its elimination leads to dwarfism , 2001, EMBO reports.

[30]  K. Shyu,et al.  Hypoxia induces discoidin domain receptor-2 expression via the p38 pathway in vascular smooth muscle cells to increase their migration. , 2008, Biochemical and biophysical research communications.

[31]  R. Sinkus,et al.  High-resolution tensor MR elastography for breast tumour detection. , 2000, Physics in medicine and biology.

[32]  B. Nordenskjöld,et al.  Hypoxia, Snail and incomplete epithelial–mesenchymal transition in breast cancer , 2009, British Journal of Cancer.

[33]  S. Friedman,et al.  DDR2 receptor promotes MMP-2-mediated proliferation and invasion by hepatic stellate cells. , 2001, The Journal of clinical investigation.

[34]  I. Badiola,et al.  Downregulation of discoidin domain receptor 2 in A375 human melanoma cells reduces its experimental liver metastasis ability. , 2011, Oncology reports.

[35]  Valerie M. Weaver,et al.  A tense situation: forcing tumour progression , 2009, Nature Reviews Cancer.

[36]  L. Yao,et al.  An essential role of discoidin domain receptor 2 (DDR2) in osteoblast differentiation and chondrocyte maturation via modulation of Runx2 activation , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[37]  F. Portillo,et al.  Transcriptional regulation of cadherins during development and carcinogenesis. , 2004, The International journal of developmental biology.

[38]  V. Falanga,et al.  Low oxygen tension stimulates collagen synthesis and COL1A1 transcription through the action of TGF‐β1 , 2002, Journal of cellular physiology.

[39]  K. Miyazawa,et al.  Discoidin domain receptor 2 is associated with the increased expression of matrix metalloproteinase-13 in synovial fibroblasts of rheumatoid arthritis , 2009, Molecular and Cellular Biochemistry.

[40]  M. Ho,et al.  DDR1 regulates the stabilization of cell surface E‐cadherin and E‐cadherin‐mediated cell aggregation , 2010, Journal of cellular physiology.

[41]  M. Nieto,et al.  The snail superfamily of zinc-finger transcription factors , 2002, Nature Reviews Molecular Cell Biology.

[42]  T. Miura,et al.  Prolonged hypoxia accelerates the posttranscriptional process of collagen synthesis in cultured fibroblasts. , 2002, Life sciences.

[43]  A. G. Herreros,et al.  The transcription factor Snail is a repressor of E-cadherin gene expression in epithelial tumour cells , 2000, Nature Cell Biology.

[44]  L. Yao,et al.  A host deficiency of discoidin domain receptor 2 (DDR2) inhibits both tumour angiogenesis and metastasis , 2014, The Journal of pathology.